Literature DB >> 33456152

Vancomycin-induced linear IgA bullous dermatosis.

Claire J Wiggins1, Susan Y Chon1.   

Abstract

Adverse medication side effects are not uncommon in the inpatient setting, where polypharmacy is the norm. Linear IgA bullous dermatosis (LABD) can be a cutaneous side effect of commonly used inpatient medications, such as vancomycin. Symptoms of LABD can be severe, and proper recognition of this drug-induced disease is important to ensuring proper treatment, including the removal of the inciting agent. This report describes a case of vancomycin-associated LABD in a 66-year-old man and the proper management of drug-induced LABD.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Adverse drug effect; LABD; immunotherapy; linear IgA bullous dermatosis

Year:  2020        PMID： 33456152      PMCID： PMC7785186          DOI： 10.1080/08998280.2020.1809759

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  8 in total

Review 1.  Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.

Authors:  Judith Lammer; Rüdiger Hein; Sophie Roenneberg; Tilo Biedermann; Thomas Volz
Journal:  Acta Derm Venereol       Date:  2019-05-01       Impact factor: 4.437

2.  Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses.

Authors:  E Willsteed; B S Bhogal; M M Black; P McKee; F Wojnarowska
Journal:  J Cutan Pathol       Date:  1990-06       Impact factor: 1.587

3.  Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults.

Authors:  J Gottlieb; S Ingen-Housz-Oro; M Alexandre; S Grootenboer-Mignot; F Aucouturier; E Sbidian; E Tancrede; P Schneider; E Regnier; C Picard-Dahan; E Begon; C Pauwels; K Cury; S Hüe; C Bernardeschi; N Ortonne; F Caux; P Wolkenstein; O Chosidow; C Prost-Squarcioni
Journal:  Br J Dermatol       Date:  2017-05-15       Impact factor: 9.302

Review 4.  Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.

Authors:  M A Waldman; D R Black; J P Callen
Journal:  Clin Exp Dermatol       Date:  2004-11       Impact factor: 3.470

5.  Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.

Authors:  April Wang Armstrong; Amin Fazeli; Shih Wei Yeh; Bonnie T Mackool; Vincent Liu
Journal:  J Cutan Pathol       Date:  2004-05       Impact factor: 1.587

6.  Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.

Authors:  Caterina P Minniti; Kara-Marie H Delaney; Alexander M Gorbach; Dihua Xu; Chyi-Chia Richard Lee; Nitin Malik; Antony Koroulakis; Matthew Antalek; Jordan Maivelett; Marlene Peters-Lawrence; Enrico M Novelli; Sophie M Lanzkron; Karen C Axelrod; Gregory J Kato
Journal:  Am J Hematol       Date:  2013-09-19       Impact factor: 10.047

7.  Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms.

Authors:  J Chanal; S Ingen-Housz-Oro; N Ortonne; T A Duong; M Thomas; L Valeyrie-Allanore; B Lebrun-Vignes; C André; J C Roujeau; O Chosidow; P Wolkenstein
Journal:  Br J Dermatol       Date:  2013-11       Impact factor: 9.302

Review 8.  Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.

Authors:  Rohit Kakar; Holly Paugh; Christine Jaworsky
Journal:  Dermatology       Date:  2013-10-11       Impact factor: 5.366
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.